- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04214262
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
Study Overview
Status
Detailed Description
PRIMARY OBJECTIVE:
I. To compare overall survival (OS) in patients with inoperable, early stage non-small cell lung cancer (NSCLC) randomized to stereotactic body radiation therapy (SBRT) with or without atezolizumab.
SECONDARY OBJECTIVES:
I. To compare investigator-assessed progression-free survival (IA-PFS) between the arms.
II. To compare progression free survival (PFS) by blinded independent centralized review (BIRC) between the arms in a random subset of patients.
III. To evaluate distant, locoregional, and local failure rates within each treatment arm.
IV. To evaluate the frequency and severity of toxicities within each treatment arm.
ADDITIONAL OBJECTIVE:
I. To collect specimens for banking.
HEALTH-RELATED QUALITY OF LIFE (HRQOL) OBJECTIVE:
I. This objective will not be met, as the study was closed following the first interim analysis.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM A: Patients receive atezolizumab intravenously (IV) over 30-60 minutes on day 1 of each cycle. Treatment repeats every 21 days for 8 cycles in the absence of disease progression or unacceptable toxicity. Starting on day 1 cycle 3, patients also undergo SBRT for 3-8 treatments every 2 days or once daily (QD) over 1-3 weeks. Patients undergo fludeoxyglucose F-18 (FDG)-positron emission tomography/computed tomography (PET/CT) during screening. Patients undergo blood sample collection and CT scans throughout the trial.
ARM B: Beginning 21 days after randomization, patients undergo SBRT for 3-8 treatments every 2 days or QD over 1-3 weeks. Patients undergo FDG-PET/CT during screening. Patients undergo blood sample collection and CT scans throughout the trial.
After completion of study treatment, patients are followed for 5 years after randomization.
Study Type
Enrollment (Estimated)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Alaska
-
Anchorage, Alaska, United States, 99508
- Providence Alaska Medical Center
-
-
Arkansas
-
Jonesboro, Arkansas, United States, 72401
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
-
Little Rock, Arkansas, United States, 72205
- University of Arkansas for Medical Sciences
-
-
California
-
Antioch, California, United States, 94531
- Kaiser Permanente-Deer Valley Medical Center
-
Bakersfield, California, United States, 93301
- AIS Cancer Center at San Joaquin Community Hospital
-
Berkeley, California, United States, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Beverly Hills, California, United States, 90211
- Tower Cancer Research Foundation
-
Dublin, California, United States, 94568
- Kaiser Permanente Dublin
-
Fremont, California, United States, 94538
- Kaiser Permanente-Fremont
-
Fresno, California, United States, 93720
- Kaiser Permanente-Fresno
-
Loma Linda, California, United States, 92354
- Loma Linda University Medical Center
-
Loma Linda, California, United States, 92357
- Veterans Affairs Loma Linda Healthcare System
-
Long Beach, California, United States, 90822
- Tibor Rubin VA Medical Center
-
Los Angeles, California, United States, 90033
- USC / Norris Comprehensive Cancer Center
-
Los Angeles, California, United States, 90048
- Cedars-Sinai Medical Center
-
Los Angeles, California, United States, 90033
- Los Angeles General Medical Center
-
Marysville, California, United States, 95901
- Fremont - Rideout Cancer Center
-
Modesto, California, United States, 95355
- Memorial Medical Center
-
Modesto, California, United States, 95356
- Kaiser Permanente-Modesto
-
Oakland, California, United States, 94611
- Kaiser Permanente-Oakland
-
Orange, California, United States, 92868
- UC Irvine Health/Chao Family Comprehensive Cancer Center
-
Orange, California, United States, 92868
- Saint Joseph Hospital - Orange
-
Palm Springs, California, United States, 92262
- Desert Regional Medical Center
-
Richmond, California, United States, 94801
- Kaiser Permanente-Richmond
-
Roseville, California, United States, 95678
- The Permanente Medical Group-Roseville Radiation Oncology
-
Roseville, California, United States, 95661
- Kaiser Permanente-Roseville
-
Roseville, California, United States, 95661
- Sutter Cancer Centers Radiation Oncology Services-Roseville
-
Roseville, California, United States, 95661
- Sutter Roseville Medical Center
-
Sacramento, California, United States, 95816
- Sutter Medical Center Sacramento
-
Sacramento, California, United States, 95817
- University of California Davis Comprehensive Cancer Center
-
Sacramento, California, United States, 95814
- Kaiser Permanente Downtown Commons
-
Sacramento, California, United States, 95823
- Kaiser Permanente-South Sacramento
-
San Francisco, California, United States, 94121
- Veterans Affairs Medical Center - San Francisco
-
San Francisco, California, United States, 94115
- Kaiser Permanente-San Francisco
-
San Francisco, California, United States, 94115
- California Pacific Medical Center-Pacific Campus
-
San Jose, California, United States, 95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Leandro, California, United States, 94577
- Kaiser Permanente San Leandro
-
San Rafael, California, United States, 94903
- Kaiser San Rafael-Gallinas
-
Santa Clara, California, United States, 95051
- Kaiser Permanente Medical Center - Santa Clara
-
Santa Rosa, California, United States, 95403
- Kaiser Permanente-Santa Rosa
-
South San Francisco, California, United States, 94080
- Kaiser Permanente Cancer Treatment Center
-
South San Francisco, California, United States, 94080
- Kaiser Permanente-South San Francisco
-
Stockton, California, United States, 95210
- Kaiser Permanente-Stockton
-
Truckee, California, United States, 96161
- Gene Upshaw Memorial Tahoe Forest Cancer Center
-
Vacaville, California, United States, 95688
- Kaiser Permanente Medical Center-Vacaville
-
Vallejo, California, United States, 94589
- Kaiser Permanente-Vallejo
-
Vallejo, California, United States, 94589
- Sutter Solano Medical Center/Cancer Center
-
Walnut Creek, California, United States, 94596
- Kaiser Permanente-Walnut Creek
-
Whittier, California, United States, 90602
- Presbyterian Intercommunity Hospital
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Rocky Mountain Regional VA Medical Center
-
Aurora, Colorado, United States, 80045
- UCHealth University of Colorado Hospital
-
Colorado Springs, Colorado, United States, 80907
- Penrose-Saint Francis Healthcare
-
Colorado Springs, Colorado, United States, 80909
- UCHealth Memorial Hospital Central
-
Colorado Springs, Colorado, United States, 80920
- Memorial Hospital North
-
Denver, Colorado, United States, 80205
- Kaiser Permanente-Franklin
-
Fort Collins, Colorado, United States, 80524
- Poudre Valley Hospital
-
Fort Collins, Colorado, United States, 80528
- Cancer Care and Hematology-Fort Collins
-
Greeley, Colorado, United States, 80631
- UCHealth Greeley Hospital
-
Greeley, Colorado, United States, 80631
- Banner North Colorado Medical Center
-
Highlands Ranch, Colorado, United States, 80129
- UCHealth Highlands Ranch Hospital
-
Lafayette, Colorado, United States, 80026
- Kaiser Permanente-Rock Creek
-
Lone Tree, Colorado, United States, 80124
- Kaiser Permanente-Lone Tree
-
Loveland, Colorado, United States, 80538
- Medical Center of the Rockies
-
Loveland, Colorado, United States, 80539
- Banner North Colorado Medical Center - Loveland Campus
-
-
Connecticut
-
Fairfield, Connecticut, United States, 06824
- Smilow Cancer Hospital Care Center-Fairfield
-
Greenwich, Connecticut, United States, 06830
- Smilow Cancer Hospital Care Center at Greenwich
-
Guilford, Connecticut, United States, 06437
- Smilow Cancer Hospital Care Center - Guilford
-
Hamden, Connecticut, United States, 06518
- Smilow Cancer Hospital-Hamden Care Center
-
New Haven, Connecticut, United States, 06520
- Yale University
-
North Haven, Connecticut, United States, 06473
- Yale-New Haven Hospital North Haven Medical Center
-
Trumbull, Connecticut, United States, 06611
- Smilow Cancer Hospital Care Center-Trumbull
-
Waterford, Connecticut, United States, 06385
- Smilow Cancer Hospital Care Center - Waterford
-
-
Delaware
-
Dover, Delaware, United States, 19901
- Bayhealth Hospital Kent Campus
-
Millville, Delaware, United States, 19967
- Beebe South Coastal Health Campus
-
Newark, Delaware, United States, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, United States, 19713
- Medical Oncology Hematology Consultants PA
-
Rehoboth Beach, Delaware, United States, 19971
- Beebe Health Campus
-
-
District of Columbia
-
Washington D.C., District of Columbia, United States, 20037
- George Washington University Medical Center
-
-
Florida
-
Aventura, Florida, United States, 33180
- GenesisCare USA - Aventura FP
-
Aventura, Florida, United States, 33180
- GenesisCare USA - Aventura
-
Jupiter, Florida, United States, 33458
- Jupiter Medical Center
-
Orlando, Florida, United States, 32806
- Orlando Health Cancer Institute
-
Pembroke Pines, Florida, United States, 33028
- Memorial Hospital West
-
Plantation, Florida, United States, 33324
- GenesisCare USA - Plantation
-
Sarasota, Florida, United States, 34239
- Sarasota Memorial Hospital
-
Sarasota, Florida, United States, 34232
- Florida Cancer Specialists - Sarasota
-
Sarasota, Florida, United States, 34236
- Florida Cancer Specialists - Sarasota Downtown
-
Sarasota, Florida, United States, 34243
- Sarasota Memorial Health Care Center at University Parkway
-
-
Georgia
-
Augusta, Georgia, United States, 30912
- Augusta University Medical Center
-
Augusta, Georgia, United States, 30901
- Augusta Oncology Associates PC-D'Antignac
-
Savannah, Georgia, United States, 31405
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
-
Savannah, Georgia, United States, 31404
- Memorial Health University Medical Center
-
-
Hawaii
-
Honolulu, Hawaii, United States, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, United States, 96817
- The Cancer Center of Hawaii-Liliha
-
Honolulu, Hawaii, United States, 96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
Honolulu, Hawaii, United States, 96813
- Queen's Cancer Cenrer - POB I
-
Honolulu, Hawaii, United States, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, United States, 96817
- Queen's Cancer Center - Kuakini
-
‘Aiea, Hawaii, United States, 96701
- Hawaii Cancer Care - Westridge
-
‘Aiea, Hawaii, United States, 96701
- Pali Momi Medical Center
-
-
Idaho
-
Boise, Idaho, United States, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
Caldwell, Idaho, United States, 83605
- Saint Alphonsus Cancer Care Center-Caldwell
-
Nampa, Idaho, United States, 83687
- Saint Alphonsus Cancer Care Center-Nampa
-
-
Illinois
-
Aurora, Illinois, United States, 60504
- Rush-Copley Medical Center
-
Bloomington, Illinois, United States, 61704
- Illinois CancerCare-Bloomington
-
Bloomington, Illinois, United States, 61701
- OSF Saint Joseph Medical Center
-
Canton, Illinois, United States, 61520
- Illinois CancerCare-Canton
-
Carthage, Illinois, United States, 62321
- Illinois CancerCare-Carthage
-
Chicago, Illinois, United States, 60612
- University of Illinois
-
Chicago, Illinois, United States, 60612
- Jesse Brown Veterans Affairs Medical Center
-
Decatur, Illinois, United States, 62526
- Decatur Memorial Hospital
-
Effingham, Illinois, United States, 62401
- Crossroads Cancer Center
-
Eureka, Illinois, United States, 61530
- Illinois CancerCare-Eureka
-
Galesburg, Illinois, United States, 61401
- Western Illinois Cancer Treatment Center
-
Galesburg, Illinois, United States, 61401
- Illinois CancerCare-Galesburg
-
Kewanee, Illinois, United States, 61443
- Illinois CancerCare-Kewanee Clinic
-
Macomb, Illinois, United States, 61455
- Illinois CancerCare-Macomb
-
Maywood, Illinois, United States, 60153
- Loyola University Medical Center
-
Ottawa, Illinois, United States, 61350
- Illinois CancerCare-Ottawa Clinic
-
Pekin, Illinois, United States, 61554
- Illinois CancerCare-Pekin
-
Peoria, Illinois, United States, 61636
- Methodist Medical Center of Illinois
-
Peoria, Illinois, United States, 61637
- OSF Saint Francis Medical Center
-
Peoria, Illinois, United States, 61615
- Illinois CancerCare-Peoria
-
Peoria, Illinois, United States, 61615
- OSF Saint Francis Radiation Oncology at Peoria Cancer Center
-
Peru, Illinois, United States, 61354
- Illinois CancerCare-Peru
-
Princeton, Illinois, United States, 61356
- Illinois CancerCare-Princeton
-
Rockford, Illinois, United States, 61114
- UW Health Carbone Cancer Center Rockford
-
Springfield, Illinois, United States, 62702
- Southern Illinois University School of Medicine
-
Springfield, Illinois, United States, 62702
- Springfield Clinic
-
Springfield, Illinois, United States, 62781
- Springfield Memorial Hospital
-
Urbana, Illinois, United States, 61801
- Carle Cancer Center
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Indiana University/Melvin and Bren Simon Cancer Center
-
Indianapolis, Indiana, United States, 46227
- Community Cancer Center South
-
-
Iowa
-
Ames, Iowa, United States, 50010
- McFarland Clinic - Ames
-
Clive, Iowa, United States, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, United States, 50325
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic
-
Creston, Iowa, United States, 50801
- Greater Regional Medical Center
-
Des Moines, Iowa, United States, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, United States, 50314
- UI Health Care Mission Cancer and Blood - Laurel Clinic
-
West Des Moines, Iowa, United States, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Wichita, Kansas, United States, 67214
- Ascension Via Christi Hospitals Wichita
-
-
Kentucky
-
Lexington, Kentucky, United States, 40509
- Saint Joseph Hospital East
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70805
- LSU Health Baton Rouge-North Clinic
-
Baton Rouge, Louisiana, United States, 70809
- Louisiana Hematology Oncology Associates LLC
-
Baton Rouge, Louisiana, United States, 70809
- Mary Bird Perkins Cancer Center
-
Baton Rouge, Louisiana, United States, 70808
- Our Lady of the Lake Physician Group
-
Houma, Louisiana, United States, 70360
- Mary Bird Perkins Cancer Center - Houma
-
Houma, Louisiana, United States, 70360
- Terrebonne General Medical Center
-
Metairie, Louisiana, United States, 70006
- East Jefferson General Hospital
-
-
Maryland
-
Towson, Maryland, United States, 21204
- UM Saint Joseph Medical Center
-
-
Massachusetts
-
Beverly, Massachusetts, United States, 01915
- Beverly Hospital
-
Burlington, Massachusetts, United States, 01805
- Lahey Hospital and Medical Center
-
Gloucester, Massachusetts, United States, 01930
- Addison Gilbert Hospital
-
Winchester, Massachusetts, United States, 01890
- Beth Israel Deaconess Medical Center/Winchester Center for Cancer Care
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Brighton, Michigan, United States, 48114
- Trinity Health Medical Center - Brighton
-
Canton, Michigan, United States, 48188
- Trinity Health Medical Center - Canton
-
Chelsea, Michigan, United States, 48118
- Chelsea Hospital
-
Clarkston, Michigan, United States, 48346
- Michigan Healthcare Professionals Clarkston
-
Dearborn, Michigan, United States, 48124
- Corewell Health Dearborn Hospital
-
Detroit, Michigan, United States, 48202
- Henry Ford Hospital
-
Detroit, Michigan, United States, 48236
- Henry Ford Health Saint John Hospital
-
Farmington Hills, Michigan, United States, 48334
- Michigan Healthcare Professionals Farmington
-
Farmington Hills, Michigan, United States, 48336
- Corewell Health Farmington Hills Hospital
-
Flint, Michigan, United States, 48503
- Genesys Hurley Cancer Institute
-
Kalamazoo, Michigan, United States, 49007
- West Michigan Cancer Center
-
Lansing, Michigan, United States, 48912
- University of Michigan Health - Sparrow Lansing
-
Livonia, Michigan, United States, 48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Macomb, Michigan, United States, 48044
- Michigan Healthcare Professionals Macomb
-
Niles, Michigan, United States, 49120
- Corewell Health Lakeland Hospitals - Niles Hospital
-
Novi, Michigan, United States, 48374
- Henry Ford Health Providence Novi Hospital
-
Pontiac, Michigan, United States, 48341
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Pontiac, Michigan, United States, 48341
- Michigan Healthcare Professionals Pontiac
-
Royal Oak, Michigan, United States, 48073
- Corewell Health William Beaumont University Hospital
-
Saginaw, Michigan, United States, 48604
- Oncology Hematology Associates of Saginaw Valley PC
-
Saginaw, Michigan, United States, 48601
- MyMichigan Medical Center Saginaw
-
Saint Joseph, Michigan, United States, 49085
- Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
-
Saint Joseph, Michigan, United States, 49085
- Corewell Health Lakeland Hospitals - Saint Joseph Hospital
-
Southfield, Michigan, United States, 48075
- Henry Ford Health Providence Southfield Hospital
-
Tawas City, Michigan, United States, 48764
- MyMichigan Medical Center Tawas
-
Traverse City, Michigan, United States, 49684
- Munson Medical Center
-
Troy, Michigan, United States, 48098
- Michigan Healthcare Professionals Troy
-
Troy, Michigan, United States, 48085
- Corewell Health Beaumont Troy Hospital
-
Warren, Michigan, United States, 48093
- Henry Ford Health Warren Hospital
-
West Branch, Michigan, United States, 48661
- Saint Mary's Oncology/Hematology Associates of West Branch
-
Wyoming, Michigan, United States, 49519
- University of Michigan Health - West
-
-
Minnesota
-
Bemidji, Minnesota, United States, 56601
- Sanford Joe Lueken Cancer Center
-
Duluth, Minnesota, United States, 55805
- Miller-Dwan Hospital
-
Minneapolis, Minnesota, United States, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, United States, 55407
- Abbott-Northwestern Hospital
-
Saint Cloud, Minnesota, United States, 56303
- Coborn Cancer Center at Saint Cloud Hospital
-
Saint Louis Park, Minnesota, United States, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Paul, Minnesota, United States, 55101
- Regions Hospital
-
-
Mississippi
-
Columbus, Mississippi, United States, 39705
- Baptist Memorial Hospital and Cancer Center-Golden Triangle
-
Grenada, Mississippi, United States, 38901
- Baptist Cancer Center-Grenada
-
Jackson, Mississippi, United States, 39216
- University of Mississippi Medical Center
-
New Albany, Mississippi, United States, 38652
- Baptist Memorial Hospital and Cancer Center-Union County
-
Oxford, Mississippi, United States, 38655
- Baptist Memorial Hospital and Cancer Center-Oxford
-
Southhaven, Mississippi, United States, 38671
- Baptist Memorial Hospital and Cancer Center-Desoto
-
-
Missouri
-
Cape Girardeau, Missouri, United States, 63703
- Saint Francis Medical Center
-
Farmington, Missouri, United States, 63640
- Parkland Health Center - Farmington
-
Joplin, Missouri, United States, 64804
- Freeman Health System
-
Kansas City, Missouri, United States, 64128
- Kansas City Veterans Affairs Medical Center
-
Rolla, Missouri, United States, 65401
- Phelps Health Delbert Day Cancer Institute
-
Saint Joseph, Missouri, United States, 64506
- Heartland Regional Medical Center
-
Sainte Genevieve, Missouri, United States, 63670
- Sainte Genevieve County Memorial Hospital
-
Springfield, Missouri, United States, 65807
- CoxHealth South Hospital
-
Springfield, Missouri, United States, 65804
- Mercy Hospital Springfield
-
St Louis, Missouri, United States, 63131
- Missouri Baptist Medical Center
-
Sullivan, Missouri, United States, 63080
- Missouri Baptist Sullivan Hospital
-
Sunset Hills, Missouri, United States, 63127
- BJC Outpatient Center at Sunset Hills
-
-
Montana
-
Billings, Montana, United States, 59101
- Billings Clinic Cancer Center
-
Bozeman, Montana, United States, 59715
- Bozeman Health Deaconess Hospital
-
Butte, Montana, United States, 59701
- Saint James Community Hospital and Cancer Treatment Center
-
Great Falls, Montana, United States, 59405
- Benefis Sletten Cancer Institute
-
-
Nebraska
-
Bellevue, Nebraska, United States, 68123
- Nebraska Medicine-Bellevue
-
Grand Island, Nebraska, United States, 68803
- Nebraska Cancer Specialists/Oncology Hematology West PC
-
Kearney, Nebraska, United States, 68847
- CHI Health Good Samaritan
-
Omaha, Nebraska, United States, 68198
- University of Nebraska Medical Center
-
Omaha, Nebraska, United States, 68118
- Nebraska Medicine-Village Pointe
-
-
New Jersey
-
Basking Ridge, New Jersey, United States, 07920
- Memorial Sloan Kettering Basking Ridge
-
Camden, New Jersey, United States, 08103
- Cooper Hospital University Medical Center
-
Middletown, New Jersey, United States, 07748
- Memorial Sloan Kettering Monmouth
-
Montvale, New Jersey, United States, 07645
- Memorial Sloan Kettering Bergen
-
Pennington, New Jersey, United States, 08534
- Capital Health Medical Center-Hopewell
-
Voorhees Township, New Jersey, United States, 08043
- MD Anderson Cancer Center at Cooper-Voorhees
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87106
- University of New Mexico Cancer Center
-
-
New York
-
Brooklyn, New York, United States, 11215
- New York-Presbyterian/Brooklyn Methodist Hospital
-
Buffalo, New York, United States, 14263
- Roswell Park Cancer Institute
-
Commack, New York, United States, 11725
- Memorial Sloan Kettering Commack
-
Cooperstown, New York, United States, 13326
- Mary Imogene Bassett Hospital
-
East Hills, New York, United States, 11548
- The Cancer Institute at Saint Francis Hospital
-
Elmira, New York, United States, 14905
- Arnot Ogden Medical Center/Falck Cancer Center
-
Harrison, New York, United States, 10604
- Memorial Sloan Kettering Westchester
-
Lake Success, New York, United States, 11042
- Northwell Health/Center for Advanced Medicine
-
New York, New York, United States, 10065
- Memorial Sloan Kettering Cancer Center
-
New York, New York, United States, 10019
- Mount Sinai West
-
New York, New York, United States, 10029
- Mount Sinai Hospital
-
New York, New York, United States, 10011
- Mount Sinai Chelsea
-
New York, New York, United States, 10075
- Lenox Hill Hospital
-
New York, New York, United States, 10065
- Manhattan Eye Ear and Throat Hospital
-
Syracuse, New York, United States, 13210
- State University of New York Upstate Medical University
-
The Bronx, New York, United States, 10461
- Montefiore Medical Center-Einstein Campus
-
The Bronx, New York, United States, 10467
- Montefiore Medical Center - Moses Campus
-
Uniondale, New York, United States, 11553
- Memorial Sloan Kettering Nassau
-
West Islip, New York, United States, 11795
- Good Samaritan University Hospital
-
-
North Carolina
-
Asheville, North Carolina, United States, 28806
- Messino Cancer Centers
-
Cary, North Carolina, United States, 27518
- UNC Health Cancer Care Cary
-
Charlotte, North Carolina, United States, 28204
- Novant Health Presbyterian Medical Center
-
Durham, North Carolina, United States, 27705
- Durham VA Medical Center
-
Garner, North Carolina, United States, 27529
- UNC Health Cancer Care Garner
-
Gastonia, North Carolina, United States, 28054
- CaroMont Regional Medical Center
-
Hendersonville, North Carolina, United States, 28791
- Margaret R Pardee Memorial Hospital
-
Huntersville, North Carolina, United States, 28078
- Novant Health Cancer Institute - Huntersville
-
Kernersville, North Carolina, United States, 27284
- Novant Health Cancer Institute - Kernersville
-
Matthews, North Carolina, United States, 28105
- Novant Health Cancer Institute - Matthews
-
New Bern, North Carolina, United States, 28561
- CarolinaEast Medical Center
-
Pinehurst, North Carolina, United States, 28374
- FirstHealth of the Carolinas-Moore Regional Hospital
-
Raleigh, North Carolina, United States, 27607
- UNC Health Cancer Care Raleigh
-
Raleigh, North Carolina, United States, 27614
- UNC Health Cancer Care Wakefield
-
Supply, North Carolina, United States, 28462
- Novant Cancer Institute Radiation Oncology - Supply
-
Wilmington, North Carolina, United States, 28401
- Novant Health New Hanover Regional Medical Center
-
Wilmington, North Carolina, United States, 28401
- Novant Health Cancer Institute Radiation Oncology - Wilmington
-
Winston-Salem, North Carolina, United States, 27103
- Novant Health Forsyth Medical Center
-
-
North Dakota
-
Bismarck, North Dakota, United States, 58501
- Sanford Bismarck Medical Center
-
Fargo, North Dakota, United States, 58122
- Sanford Roger Maris Cancer Center
-
Fargo, North Dakota, United States, 58122
- Sanford Broadway Medical Center
-
-
Ohio
-
Centerville, Ohio, United States, 45459
- Miami Valley Hospital South
-
Chillicothe, Ohio, United States, 45601
- Adena Regional Medical Center
-
Cincinnati, Ohio, United States, 45220
- Good Samaritan Hospital - Cincinnati
-
Cleveland, Ohio, United States, 44109
- MetroHealth Medical Center
-
Columbus, Ohio, United States, 43210
- Ohio State University Comprehensive Cancer Center
-
Columbus, Ohio, United States, 43219
- The Mark H Zangmeister Center
-
Dayton, Ohio, United States, 45409
- Miami Valley Hospital
-
Dayton, Ohio, United States, 45415
- Miami Valley Hospital North
-
Dayton, Ohio, United States, 45409
- Premier Blood and Cancer Center
-
Franklin, Ohio, United States, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Grove City, Ohio, United States, 43123
- Mount Carmel Grove City Hospital
-
Troy, Ohio, United States, 45373
- Upper Valley Medical Center
-
Westerville, Ohio, United States, 43081
- Saint Ann's Hospital
-
Zanesville, Ohio, United States, 43701
- Genesis Healthcare System Cancer Care Center
-
-
Oklahoma
-
Lawton, Oklahoma, United States, 73505
- Cancer Centers of Southwest Oklahoma Research
-
Oklahoma City, Oklahoma, United States, 73104
- University of Oklahoma Health Sciences Center
-
Oklahoma City, Oklahoma, United States, 73120
- Mercy Hospital Oklahoma City
-
-
Oregon
-
Clackamas, Oregon, United States, 97015
- Clackamas Radiation Oncology Center
-
Gresham, Oregon, United States, 97030
- Legacy Mount Hood Medical Center
-
Portland, Oregon, United States, 97210
- Legacy Good Samaritan Hospital and Medical Center
-
Portland, Oregon, United States, 97213
- Providence Portland Medical Center
-
Portland, Oregon, United States, 97225
- Providence Saint Vincent Medical Center
-
Tualatin, Oregon, United States, 97062
- Legacy Meridian Park Hospital
-
-
Pennsylvania
-
Allentown, Pennsylvania, United States, 18103
- Lehigh Valley Hospital-Cedar Crest
-
Danville, Pennsylvania, United States, 17822
- Geisinger Medical Center
-
Drexel Hill, Pennsylvania, United States, 19026
- Delaware County Memorial Hospital
-
East Stroudsburg, Pennsylvania, United States, 18301
- Pocono Medical Center
-
Hershey, Pennsylvania, United States, 17033-0850
- Penn State Milton S Hershey Medical Center
-
Indiana, Pennsylvania, United States, 15701
- IRMC Cancer Center
-
Lewisburg, Pennsylvania, United States, 17837
- Geisinger Medical Oncology-Lewisburg
-
Monroeville, Pennsylvania, United States, 15146
- UPMC Cancer Center - Monroeville
-
Philadelphia, Pennsylvania, United States, 19107
- Thomas Jefferson University Hospital
-
Philadelphia, Pennsylvania, United States, 19114
- Jefferson Torresdale Hospital
-
Pittsburgh, Pennsylvania, United States, 15232
- University of Pittsburgh Cancer Institute (UPCI)
-
Pittsburgh, Pennsylvania, United States, 15232
- UPMC-Shadyside Hospital
-
Pittsburgh, Pennsylvania, United States, 15215
- UPMC-Saint Margaret
-
Pottsville, Pennsylvania, United States, 17901
- Geisinger Cancer Services-Pottsville
-
Selinsgrove, Pennsylvania, United States, 17870
- Geisinger Medical Oncology-Selinsgrove
-
West Reading, Pennsylvania, United States, 19611
- Reading Hospital
-
Wilkes-Barre, Pennsylvania, United States, 18711
- Geisinger Wyoming Valley/Henry Cancer Center
-
Willow Grove, Pennsylvania, United States, 19090
- Asplundh Cancer Pavilion
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02903
- Rhode Island Hospital
-
-
South Carolina
-
Bluffton, South Carolina, United States, 29910
- Saint Joseph's/Candler - Bluffton Campus
-
Florence, South Carolina, United States, 29506
- McLeod Regional Medical Center
-
Gaffney, South Carolina, United States, 29341
- Gibbs Cancer Center-Gaffney
-
Greenville, South Carolina, United States, 29607
- Saint Francis Cancer Center
-
Greenville, South Carolina, United States, 29601
- Saint Francis Hospital
-
Greer, South Carolina, United States, 29651
- Gibbs Cancer Center-Pelham
-
Spartanburg, South Carolina, United States, 29303
- Spartanburg Medical Center
-
-
South Dakota
-
Sioux Falls, South Dakota, United States, 57117-5134
- Sanford USD Medical Center - Sioux Falls
-
Sioux Falls, South Dakota, United States, 57104
- Sanford Cancer Center Oncology Clinic
-
-
Tennessee
-
Collierville, Tennessee, United States, 38017
- Baptist Memorial Hospital and Cancer Center-Collierville
-
Kingsport, Tennessee, United States, 37660
- Ballad Health Cancer Care - Kingsport
-
Kingsport, Tennessee, United States, 37660
- Wellmont Holston Valley Hospital and Medical Center
-
Memphis, Tennessee, United States, 38120
- Baptist Memorial Hospital and Cancer Center-Memphis
-
-
Texas
-
Conroe, Texas, United States, 77384
- MD Anderson in The Woodlands
-
Houston, Texas, United States, 77030
- M D Anderson Cancer Center
-
Houston, Texas, United States, 77079
- MD Anderson West Houston
-
League City, Texas, United States, 77573
- MD Anderson League City
-
Sugar Land, Texas, United States, 77478
- MD Anderson in Sugar Land
-
-
Utah
-
Salt Lake City, Utah, United States, 84112
- Huntsman Cancer Institute/University of Utah
-
Salt Lake City, Utah, United States, 84148
- George E Wahlen Department of Veterans Affairs Medical Center
-
-
Virginia
-
Fairfax, Virginia, United States, 22031
- Inova Schar Cancer Institute
-
Fishersville, Virginia, United States, 22939
- Augusta Health Center for Cancer and Blood Disorders
-
Norton, Virginia, United States, 24273
- Ballad Health Cancer Care - Norton
-
-
Washington
-
Seattle, Washington, United States, 98101
- Virginia Mason Medical Center
-
Vancouver, Washington, United States, 98686
- Legacy Salmon Creek Hospital
-
Vancouver, Washington, United States, 98684
- Legacy Cancer Institute Medical Oncology and Day Treatment
-
-
West Virginia
-
Charleston, West Virginia, United States, 25304
- West Virginia University Charleston Division
-
Huntington, West Virginia, United States, 25701
- Edwards Comprehensive Cancer Center
-
Wheeling, West Virginia, United States, 26003
- Wheeling Hospital/Schiffler Cancer Center
-
-
Wisconsin
-
Antigo, Wisconsin, United States, 54409
- Langlade Hospital and Cancer Center
-
Appleton, Wisconsin, United States, 54911
- ThedaCare Regional Cancer Center
-
Appleton, Wisconsin, United States, 54915
- Ascension Saint Elizabeth Hospital
-
Ashland, Wisconsin, United States, 54806
- Northwest Wisconsin Cancer Center
-
Brookfield, Wisconsin, United States, 53045
- Ascension Southeast Wisconsin Hospital - Elmbrook Campus
-
Burlington, Wisconsin, United States, 53105
- Aurora Cancer Care-Southern Lakes VLCC
-
Chilton, Wisconsin, United States, 53014
- Ascension Calumet Hospital
-
Eau Claire, Wisconsin, United States, 54701
- Marshfield Medical Center-EC Cancer Center
-
Eau Claire, Wisconsin, United States, 54701
- HSHS Sacred Heart Hospital
-
Franklin, Wisconsin, United States, 53132
- Ascension Saint Francis - Reiman Cancer Center
-
Germantown, Wisconsin, United States, 53022
- Aurora Health Care Germantown Health Center
-
Grafton, Wisconsin, United States, 53024
- Aurora Cancer Care-Grafton
-
Green Bay, Wisconsin, United States, 54311
- Aurora BayCare Medical Center
-
Green Bay, Wisconsin, United States, 54301
- Saint Vincent Hospital Cancer Center Green Bay
-
Green Bay, Wisconsin, United States, 54303
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
Green Bay, Wisconsin, United States, 54301
- Bellin Memorial Hospital
-
Kenosha, Wisconsin, United States, 53142
- Aurora Cancer Care-Kenosha South
-
La Crosse, Wisconsin, United States, 54601
- Gundersen Lutheran Medical Center
-
La Crosse, Wisconsin, United States, 54601
- Mayo Clinic Health System-Franciscan Healthcare
-
Madison, Wisconsin, United States, 53705
- William S Middleton VA Medical Center
-
Madison, Wisconsin, United States, 53792
- University of Wisconsin Carbone Cancer Center - University Hospital
-
Marinette, Wisconsin, United States, 54143
- Aurora Bay Area Medical Group-Marinette
-
Marshfield, Wisconsin, United States, 54449
- Marshfield Medical Center-Marshfield
-
Medford, Wisconsin, United States, 54451
- Aspirus Medford Hospital
-
Mequon, Wisconsin, United States, 53097
- Ascension Columbia Saint Mary's Hospital Ozaukee
-
Milwaukee, Wisconsin, United States, 53209
- Aurora Cancer Care-Milwaukee
-
Milwaukee, Wisconsin, United States, 53215
- Aurora Saint Luke's Medical Center
-
Milwaukee, Wisconsin, United States, 53233
- Aurora Sinai Medical Center
-
Milwaukee, Wisconsin, United States, 53211
- Ascension Columbia Saint Mary's Hospital - Milwaukee
-
Minocqua, Wisconsin, United States, 54548
- Marshfield Medical Center - Minocqua
-
Mukwonago, Wisconsin, United States, 53149
- ProHealth D N Greenwald Center
-
New London, Wisconsin, United States, 54961
- ThedaCare Cancer Care - New London
-
Oconomowoc, Wisconsin, United States, 53066
- ProHealth Oconomowoc Memorial Hospital
-
Oshkosh, Wisconsin, United States, 54904
- Ascension Mercy Hospital
-
Oshkosh, Wisconsin, United States, 54904
- Vince Lombardi Cancer Clinic - Oshkosh
-
Racine, Wisconsin, United States, 53406
- Aurora Cancer Care-Racine
-
Racine, Wisconsin, United States, 53405
- Ascension All Saints Hospital
-
Rhinelander, Wisconsin, United States, 54501
- Aspirus Cancer Care - James Beck Cancer Center
-
Rice Lake, Wisconsin, United States, 54868
- Marshfield Medical Center-Rice Lake
-
Sheboygan, Wisconsin, United States, 53081
- Vince Lombardi Cancer Clinic-Sheboygan
-
Sheboygan, Wisconsin, United States, 53081
- Saint Vincent Hospital Cancer Center at Sheboygan
-
Stevens Point, Wisconsin, United States, 54482
- Marshfield Medical Center-River Region at Stevens Point
-
Stevens Point, Wisconsin, United States, 54481
- Aspirus Cancer Care - Stevens Point
-
Sturgeon Bay, Wisconsin, United States, 54235-1495
- Saint Vincent Hospital Cancer Center at Sturgeon Bay
-
Summit, Wisconsin, United States, 53066
- Aurora Medical Center in Summit
-
Two Rivers, Wisconsin, United States, 54241
- Vince Lombardi Cancer Clinic-Two Rivers
-
Waukesha, Wisconsin, United States, 53188
- UW Cancer Center at ProHealth Care
-
Wausau, Wisconsin, United States, 54401
- Aspirus Regional Cancer Center
-
Wauwatosa, Wisconsin, United States, 53226
- Aurora Cancer Care-Milwaukee West
-
Wauwatosa, Wisconsin, United States, 53226
- Ascension Medical Group Southeast Wisconsin - Mayfair Road
-
West Allis, Wisconsin, United States, 53227
- Aurora West Allis Medical Center
-
Weston, Wisconsin, United States, 54476
- Marshfield Medical Center - Weston
-
Wisconsin Rapids, Wisconsin, United States, 54494
- Aspirus Cancer Care - Wisconsin Rapids
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient must have histologically or cytologically proven stage I-IIA or limited T3N0M0 non-small cell lung cancer (NSCLC), without radiographic evidence of nodal or distant involvement (N0M0). Patient may have T3 disease with the exclusion of pericardial involvement. Patients with multifocal tumors with no more than two lesions confirmed or suspected to be synchronous early stage NSCLCs are eligible provided at least one lesion is histologically or cytologically proven to be NSCLC and meets one or more high-risk features
Disease must have one or more of the following high-risk features:
- Tumor diameter >= 2 cm (inclusive of any non-solid, ground glass component) as assessed by diagnostic CT
- Tumor standard uptake value (SUV) max >= 6.2 as assessed by FDG PET/CT
- Moderately differentiated, poorly differentiated, or undifferentiated histology
- Patient must have undergone diagnostic chest CT with or without contrast (IV contrast preferred) within 42 days prior to randomization. PET-CT may be used if the CT portion is of comparable diagnostic quality to a stand-alone CT. All disease must be assessed within 42 days prior to randomization
- Patient must have undergone FDG PET/CT of chest within 90 days prior to randomization
- Patient must not have evidence of hilar or mediastinal nodal involvement. Any patient with radiographically suspicious hilar or mediastinal nodes (including features such as non-calcified nodes with a short axis diameter > 1 cm, abnormal morphology, and/or elevated FDG avidity) must undergo cytologic sampling of suspicious nodes to rule out involvement prior to randomization. Mediastinal nodal sampling for other patients is optional. For cases in which the treating physician/multidisciplinary opinion is used to define nodes as "non-suspicious" (such as long-standing, stable enlarged nodes from other medical causes), the rationale must be clearly documented within the medical record
- Patient must have undergone history and physical examination within 28 days prior to randomization
- Patient must be medically or surgically inoperable as documented by the evaluating thoracic surgeon or multi-disciplinary tumor board consensus OR patient's unwillingness to undergo surgical resection must be clearly documented
- Patient must not have received any prior treatment for the current NSCLC diagnosis
- Patient must not have undergone prior radiation to overlapping regions of the chest that, in the opinion of the treatment physician, will interfere with protocol treatment
- Patient must not have received treatment with systemic immunostimulatory or immunosuppressive agents, including corticosteroids, within 14 days prior to randomization
- Patient must be >= 18 years old
- Patient must have Zubrod performance status of 0-2
- Patient must have adequate liver function defined as aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 3 x institutional upper level of normal (IULN) within 28 days prior to randomization
- Patient must have adequate renal function defined as calculated creatinine clearance >= 30 mL/min using the following formula. The serum creatinine value used in the calculation must have been collected within 28 days prior to randomization
- Patient must have absolute neutrophil count (ANC), platelets, and hemoglobin measured within 28 days prior to randomization. The purpose of these tests is to collect baseline values to compare with on-treatment values
- Patient must have thyroid-stimulating hormone (TSH) measured within 28 days prior to randomization. The purpose of this test is to collect baseline values to compare with on-treatment values
- Patient must not have significant cardiovascular disease (New York Heart Association [NYHA] class II or greater)
- Patient must not have myocardial infarction within 90 days prior to randomization
- Patient must not have unstable arrhythmias or unstable angina
Patient must not have known left ventricular ejection fraction (LVEF) < 40% within 28 days prior to randomization
- NOTE: Assessment of LVEF by echocardiogram or multigated acquisition (MUGA) is not an eligibility requirement, but if a standard of care echocardiogram or MUGA was clinically indicated, the LVEF must not be < 40% within 28 days prior to randomization
- Patient must not have had an infection >= grade 3 (Common Terminology Criteria for Adverse Events [CTCAE] version 5.0) within 28 days prior to randomization
- Patient must not have an active autoimmune disease that has required systemic treatment in past two years (i.e., with use of disease modifying agents, corticosteroids or immunosuppressive drugs). Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency) is not considered a form of systemic treatment and is allowed
Patient must be tested for hepatitis B within 28 days prior to randomization. Patient must not have active (chronic or acute) hepatitis B virus (HBV) infection. Patients may have past or resolved HBV infection
- Active HBV is defined as having a positive hepatitis B surface antigen (HBsAg) test
- Past or resolved HBV is defined as having a negative HBsAG test and a positive total hepatitis B core antibody (HBcAb) test
Patient must be tested for hepatitis C within 28 days prior to randomization. Patient must not have active hepatitis C virus (HCV) infection
- Active HCV is defined as having a positive HCV antibody test followed by a positive HCV ribonucleic acid (RNA) test
- Patient must have pulmonary function testing to include, at a minimum, forced expiratory volume in 1 second (FEV1) and Diffusing capability of carbon monoxide (DLCO) documented within 90 days prior to randomization
- Patients with known human immunodeficiency virus (HIV) infection must be receiving anti-retroviral therapy and have an undetectable viral load at their most recent viral load test within 6 months prior to randomization
- Patient must not have a history of clinically significant interstitial lung disease or evidence of active pneumonitis on the screening chest CT
- Patients must not have a prior or concurrent malignancy whose natural history or treatment has the potential (in the opinion of the treating physician) to interfere with the safety or efficacy assessment of the investigational regimen
- Patients must not be pregnant due to the potential teratogenic side effects of the protocol treatment. Women of reproductive potential and men must have agreed to use an effective contraception method for the duration of protocol treatment, and for 5 months (150 days) after the last dose of atezolizumab. A woman is considered to be of "reproductive potential" if she has had a menses at any time in the preceding 12 consecutive months. In addition to routine contraceptive methods, "effective contraception" also includes heterosexual celibacy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) defined as a hysterectomy, bilateral oophorectomy or bilateral tubal ligation. However, if at any point a previously celibate patient chooses to become heterosexually active during the time period for use of contraceptive measures outlined in the protocol, he/she is responsible for beginning contraceptive measures. Because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother with atezolizumab, breastfeeding must be discontinued prior to randomization
- Patients of reproductive potential must have a negative serum pregnancy test within 14 days prior to randomization
- Patients must not have known active tuberculosis
Patients must not have received a live, attenuated vaccine within 28 days prior to randomization
- NOTE: All coronavirus disease 2019 (COVID-19) vaccines that have received Food and Drug Administration (FDA) approval or FDA emergency use authorization are acceptable
- Patients must not have a known history of allergic reactions attributed to compounds of similar chemical or biologic composition to atezolizumab
- Patients must not have a known history of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric antibodies, fusion proteins, or Chinese hamster ovary cell products or to any component of the atezolizumab formulation
- Patient must agree to have specimens submitted for translational medicine and banking
- Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines
- As a part of the OPEN registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system
- Patients who can complete quality of life instruments in English, French, or Spanish must agree to complete the questionnaires at the protocol-specified time points
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm A (atezolizumab, SBRT)
Patients receive atezolizumab IV over 30-60 minutes on day 1 of each cycle.
Treatment repeats every 21 days for 8 cycles in the absence of disease progression or unacceptable toxicity.
Starting on day 1 cycle 3, patients also undergo SBRT for 3-8 treatments every 2 days or QD over 1-3 weeks.
Patients undergo FDG-PET/CT during screening.
Patients undergo blood sample collection and CT scans throughout the trial.
|
Ancillary studies
Other Names:
Ancillary studies
Undergo blood sample collection
Other Names:
Given IV
Other Names:
Undergo SBRT
Other Names:
Undergo PET/CT
Other Names:
Undergo CT or PET/CT
Other Names:
Undergo FDG PET/CT
Other Names:
|
|
Active Comparator: Arm B (SBRT)
Beginning 21 days after randomization, patients undergo SBRT for 3-8 treatments every 2 days or QD over 1-3 weeks.
Patients undergo FDG-PET/CT during screening.
Patients undergo blood sample collection and CT scans throughout the trial.
|
Ancillary studies
Other Names:
Ancillary studies
Undergo blood sample collection
Other Names:
Undergo SBRT
Other Names:
Undergo PET/CT
Other Names:
Undergo CT or PET/CT
Other Names:
Undergo FDG PET/CT
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall survival
Time Frame: From date of randomization to date of death due to any cause, assessed up to 3 years
|
Will compare overall survival between patients with inoperable, T1, T2, limited T3, N0M0 (early stage) non-small cell lung cancer randomized to stereotactic body radiation therapy with or without atezolizumab.
Will be evaluated using the method of Kaplan-Meier.
For point estimates at landmark times, the associated 95% confidence interval (CI) will be calculated using Greenwood's formula and based on a log-log transformation applied on the survival function.
Hazard ratios for these outcomes will be estimated using a Cox Proportional Hazards regression model and estimated using a stratified Cox regression model.
|
From date of randomization to date of death due to any cause, assessed up to 3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Progression free survival
Time Frame: From date of randomization to date of first documentation of progression or death due to any cause, assessed up to 5 years
|
Will be evaluated using the method of Kaplan-Meier.
For point estimates at landmark times, the associated 95% CI will be calculated using Greenwood's formula and based on a log-log transformation applied on the survival function.
Hazard ratios for these outcomes will be estimated using a Cox Proportional Hazards regression model and estimated using a stratified Cox regression model.
|
From date of randomization to date of first documentation of progression or death due to any cause, assessed up to 5 years
|
|
Incidence of adverse events
Time Frame: Up to 5 years
|
This study will utilize the National Cancer Institute Common Terminology Criteria for Adverse Events version 5.0 for toxicity and serious adverse event reporting.
|
Up to 5 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in health-related quality of life
Time Frame: Up to 5 years
|
As measured by the EORTC Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) and EORTC-QLQ-LC13, between arms.
The scores at baseline and subsequent time points, as well the changes from baseline at each time point for each treatment group will be analyzed as continuous variables and compared using the two-sample t-test.
|
Up to 5 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Megan E Daly, SWOG Cancer Research Network
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neoplasms by Site
- Neoplasms
- Respiratory Tract Diseases
- Lung Diseases
- Respiratory Tract Neoplasms
- Thoracic Neoplasms
- Carcinoma, Bronchogenic
- Bronchial Neoplasms
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Investigative Techniques
- Therapeutics
- Clinical Laboratory Techniques
- Diagnostic Techniques and Procedures
- Diagnosis
- Surgical Procedures, Operative
- Carbohydrates
- Chemistry Techniques, Analytical
- Spectrum Analysis
- Radiotherapy
- Stereotaxic Techniques
- Neurosurgical Procedures
- Deoxyglucose
- Deoxy Sugars
- Fluorodeoxyglucose F18
- Specimen Handling
- Magnetic Resonance Spectroscopy
- Radiosurgery
- atezolizumab
Other Study ID Numbers
- NCI-2019-08627 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
- U10CA180888 (U.S. NIH Grant/Contract)
- S1914 (Other Identifier: CTEP)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Non-Small Cell Carcinoma
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Bristol-Myers SquibbTerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage I Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma | Non-Squamous Non-Small...United States
-
National Cancer Institute (NCI)Active, not recruitingLung Non-Squamous Non-Small Cell Carcinoma | Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7United States, Puerto Rico
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
PfizerRecruitingNon-small Cell Carcinoma | Non-Small Cell Lung Carcinoma | Non-Small Cell Lung Cancer MetastaticUnited States, United Kingdom, Canada, Taiwan, China, Belgium, Spain, Australia, France, Czechia, India, Slovakia, Japan, Finland, Greece, Denmark, Puerto Rico, Germany, Netherlands, Bulgaria, Italy, Sweden, Mexico, South Korea, Israel, A... and more
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
M.D. Anderson Cancer CenterCompletedStage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage I Lung Non-Small Cell Cancer AJCC v7 | Stage...United States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Society of Thoracic RadiologyCompletedStage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
PfizerNot yet recruitingCarcinoma | Lung Neoplasms | Non-Small Cell Lung Cancer | Lung Disease | Non-Small-Cell Lung | Carcinoma, Non-Small-Cell Lung (NSCLC) | Non-small Cell Lung Cancer, Squamous | Non-small Cell Lung Cancer, Non-squamous | Lung Cancer (NSCLC)
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedStage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Recurrent Lung Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IA...United States
Clinical Trials on Quality-of-Life Assessment
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Germ Cell Tumor | Ovarian Sarcoma | Malignant Ovarian Epithelial Tumor | Ovarian Carcinosarcoma | Ovarian Brenner Tumor | Ovarian Mucinous... and other conditionsUnited States
-
Wake Forest University Health SciencesWithdrawnLung Metastases | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Recurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Malignant NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMonoclonal Gammopathy of Undetermined Significance | Smoldering Plasma Cell MyelomaUnited States
-
Kantonsspital AarauRecruiting
-
Jonsson Comprehensive Cancer CenterWithdrawnInfiltrating Bladder Urothelial CarcinomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedBreast CarcinomaUnited States
-
Case Comprehensive Cancer CenterActive, not recruitingUnspecified Adult Solid Tumor | Tumors Metastatic to BrainUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | COVID-19 InfectionUnited States